68Ga-DOTATATE PET/CT imaging in endogenous hyperinsulinemic hypoglycemia: A tertiary endocrine centre experience
dc.contributor.author | Shah, R. | |
dc.contributor.author | Sehemby, M. | |
dc.contributor.author | Garg, R. | |
dc.contributor.author | Malhotra, G. | |
dc.contributor.author | Verma, P. | |
dc.date.accessioned | 2024-08-29T09:02:09Z | |
dc.date.available | 2024-08-29T09:02:09Z | |
dc.date.issued | 2022 | |
dc.description.division | RMC | en |
dc.format.extent | 5732 bytes | |
dc.format.mimetype | text/html | |
dc.identifier.source | Clinical Endocrinology, 2022. Vol. 96: pp. .190-199 | en |
dc.identifier.uri | http://hdl.handle.net/123456789/27250 | |
dc.language.iso | en | en |
dc.subject | 68Ga‐DOTATATE‐PET/CT | en |
dc.subject | CECT | en |
dc.subject | endogenous hyperinsulinemic hypoglycemia (EHH) | en |
dc.subject | insulinoma | en |
dc.title | 68Ga-DOTATATE PET/CT imaging in endogenous hyperinsulinemic hypoglycemia: A tertiary endocrine centre experience | en |
dc.type | Article | en |